UCSF

ZINC22443609

Substance Information

In ZINC since Heavy atoms Benign functionality
December 16th, 2008 36 Yes

Other Names:

ixafor

1,1'-(1,4-Phenylenebis(methylene))bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride

1,1'-(1,4-Phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate

1,1'-[ 1,4-phenylenebis(methylene)]bis[ 1,4,8,11-tetraazacyclotetradecane] octahydrobromide dihydrate

1,1'-[1,4-Phenylenebis ]bis[1,4,8,11-tetraazacyclotetradecane]

1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane]

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA)

1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA)

1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}

1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-

1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-, octahydrochloride

1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene

1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene octahydrobromide

1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzeneoctahydrobromide

1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane

1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane octahydrochloride

1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane

110078-46-1

110078-46-1; D08971; Mozobil (TN); Plerixafor (USAN/INN)

155148-31-5

AC1L22EQ

AC1L22ET

AC1Q3AB8

Amd 3100

AMD-3100

AMD3100

Bicyclam

bicyclam JM-2987

C28H54N8.8HCl

CHEBI:120346

CHEMBL18442

CID65014

CID65015

D08971

DB06809

DCL000041

GNA & AMD-3100

HHA & AMD-3100

I14-9461

INN

JLK-169

JM 2987

JM 3100

JM-2987

JM-3100

JM3100

L000104

LM3100

LS-173476

LS-187299

MFCD00927130

MFCD04974488

MFCD05662218

MFCD16621081

MFCD17012002

MolPort-003-940-217

Mozobil

Mozobil (TN)

NCGC00165722-01

Plerixafor (FDA

Plerixafor (hydrochloride hydrate)

Plerixafor (hydrochloride)

Plerixafor (INN/USAN)

Plerixafor 8HCl

Plerixafor 8HCl (DB06809)

Plerixafor hydrochloride

Plerixafor octahydrochloride

SDZ SID 791

SDZ-SID-791

Sid 791

SID-791

SID791

UNII-S915P5499N

USAN)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) -1.04 2.29 -156.31 9 8 3 89 505.82 4
Hi High (pH 8-9.5) 2.94 7.04 -11.84 1 10 0 126 459.499 7

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 4.72e-02 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
Purity 95% Fluorochem
Target CXCR Selleck Chemicals

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
CCR2-1-E C-C Chemokine Receptor Type 2 (cluster #1 Of 1), Eukaryotic Eukaryotes 0 0.00 Binding ≤ 10μM
CXCR4-1-E C-X-C Chemokine Receptor Type 4 (cluster #1 Of 2), Eukaryotic Eukaryotes 7 0.32 Binding ≤ 10μM
CXCR4-1-E C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic Eukaryotes 695 0.24 Functional ≤ 10μM
Z100081-4-O PBMC (Peripheral Blood Mononuclear Cells) (cluster #4 Of 4), Other Other 4 0.33 Functional ≤ 10μM
Z50607-1-O Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other Other 4 0.33 Functional ≤ 10μM
Z50658-4-O Human Immunodeficiency Virus 2 (cluster #4 Of 4), Other Other 6 0.32 Functional ≤ 10μM
Z80076-3-O CEM-SS (T-cell Leukemia) (cluster #3 Of 5), Other Other 127 0.27 Functional ≤ 10μM
Z80295-7-O MT4 (Lymphocytes) (cluster #7 Of 8), Other Other 65 0.28 Functional ≤ 10μM
Z80865-1-O GHOST CXCR4 Cell Line (cluster #1 Of 1), Other Other 1 0.35 Functional ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
CCR2_HUMAN P41597 C-C Chemokine Receptor Type 2, Human 0.1 0.39 Binding ≤ 1μM
CXCR4_HUMAN P61073 C-X-C Chemokine Receptor Type 4, Human 0.81 0.35 Binding ≤ 1μM
CXCR4_RAT O08565 C-X-C Chemokine Receptor Type 4, Rat 108 0.27 Binding ≤ 1μM
CCR2_HUMAN P41597 C-C Chemokine Receptor Type 2, Human 0.1 0.39 Binding ≤ 10μM
CXCR4_HUMAN P61073 C-X-C Chemokine Receptor Type 4, Human 0.81 0.35 Binding ≤ 10μM
CXCR4_RAT O08565 C-X-C Chemokine Receptor Type 4, Rat 108 0.27 Binding ≤ 10μM
CXCR4_HUMAN P61073 C-X-C Chemokine Receptor Type 4, Human 218.776162 0.26 Functional ≤ 10μM
Z80076 Z80076 CEM-SS (T-cell Leukemia) 127 0.27 Functional ≤ 10μM
Z80865 Z80865 GHOST CXCR4 Cell Line 0.95 0.35 Functional ≤ 10μM
Z50607 Z50607 Human Immunodeficiency Virus 1 4.2 0.33 Functional ≤ 10μM
Z50658 Z50658 Human Immunodeficiency Virus 2 5.9 0.32 Functional ≤ 10μM
Z80295 Z80295 MT4 (Lymphocytes) 65 0.28 Functional ≤ 10μM
Z100081 Z100081 PBMC (Peripheral Blood Mononuclear Cells) 3.8 0.33 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Beta defensins
Binding and entry of HIV virion
Chemokine receptors bind chemokines
G alpha (i) signalling events

Analogs ( Draw Identity 99% 90% 80% 70% )